Loss of function assays demonstrated that silencing NEAT1 attenuated the progression and angiogenesis of ESCC and rescue experiments revealed that the effects of NEAT1 were dependent on MDM2/p53 axis. This evidence concerns the gene TP53 and esophageal squamous cell carcinoma.